Literature DB >> 17680232

[Mucormycosis in paranasal sinuses].

S Volkenstein1, C Unkel, A Neumann, H Sudhoff, H Dermoumi, K Jahnke, S Dazert.   

Abstract

Three patients with mucormycosis of the paranasal sinuses were treated in the University ENT departments in Bochum and Essen in recent years. All patients were immunocompromised for different reasons and had reduced resistance against microorganism infection. They presented with symptoms of orbital complications of sinusitis. The further progress of these life-threatening fungal infections with a mortality rate between 35 and 70% depends on early and definitive diagnosis and radical surgical therapy to reduce the amount of infectious agent. The difficulties of early diagnosis by imaging, histology, microbiology, or molecular biology and postoperative therapeutic options especially with amphotericin B, liposomal amphotericin B, and posaconazole are illustrated and discussed.

Entities:  

Mesh:

Year:  2009        PMID: 17680232     DOI: 10.1007/s00106-007-1591-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  23 in total

1.  PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.

Authors:  R Bialek; F Konrad; J Kern; C Aepinus; L Cecenas; G M Gonzalez; G Just-Nübling; B Willinger; E Presterl; C Lass-Flörl; V Rickerts
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 2.  A rare presentation of zygomycosis (mucormycosis) and review of the literature.

Authors:  M Karanth; P Taniere; J Barraclough; J A Murray
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

Review 3.  [Mycoses of the head and neck].

Authors:  Audrey Rousseau; Muriel Cornet; Françoise Carnot; Daniel Brasnu; Patrick Bruneval; Cécile Badoual
Journal:  Ann Pathol       Date:  2005-04       Impact factor: 0.407

4.  Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.

Authors:  Dimitrios P Kontoyiannis; Maha Boktour; Hend Hanna; Harrys A Torres; Ray Hachem; Issam I Raad
Journal:  Cancer       Date:  2005-06-01       Impact factor: 6.860

5.  [Rhinosurgery in diseases of the orbits].

Authors:  K Jahnke
Journal:  Fortschr Kiefer Gesichtschir       Date:  1996

Review 6.  Management of systemic fungal infections: alternatives to itraconazole.

Authors:  R Herbrecht; Y Nivoix; C Fohrer; S Natarajan-Amé; V Letscher-Bru
Journal:  J Antimicrob Chemother       Date:  2005-09       Impact factor: 5.790

Review 7.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

8.  Voriconazole-induced musical hallucinations.

Authors:  A K Agrawal; L K Sherman
Journal:  Infection       Date:  2004-10       Impact factor: 3.553

Review 9.  Posaconazole: clinical pharmacology and potential for management of fungal infections.

Authors:  Andreas H Groll; Thomas J Walsh
Journal:  Expert Rev Anti Infect Ther       Date:  2005-08       Impact factor: 5.091

Review 10.  Zygomycosis.

Authors:  Corina E Gonzalez; Michael G Rinaldi; Alan M Sugar
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

View more
  1 in total

Review 1.  [Eye pain from an otorhinolaryngology perspective].

Authors:  A Neumann
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.